AzTrials
AzTrials

Sexual HealthECOSSENCT06825247

Assessment of the Psychosocial Sexual Health Competencies of Young Adults Born in France (including Those Whose Parents Were Born Abroad), and Proposal of a Sexual Health Promotion Model Adapted to the Needs Identified.

An observational study of Sexual Health, run by Centre Hospitalier le Mans at 1 site in France.

Recruiting

Looking for participants now. Contact the study team or a site below to ask about taking part.

Sites and contacts
Official record
Search all trials

Trial summary

Every year, between 4,000 and 6,000 people discover their seropositivity to the human immunodeficiency virus (HIV). The dynamics of new discoveries vary according to sexual orientation and birthplace. Read more about this study

Who is it for?
Ages 18 to 29 years
Conditions the study is for
Sexual Health
How many people
1,500 participants
Where
1 siteFrance
Study dates
1 Jun 2022to Nov 2025
Phase
Observational
Are there results?
Not yet: the study is under way

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 29 years
  • All sexes
  • No healthy volunteers
  • Adult

Study population: Young adults born in France and living in Pays de Loire

Who may be able to join

  • Aged from 18 to 29 years
  • Born in France or its territories,
  • Be able to read and write French.

Who cannot join

  • They are under guardianship,
  • They refuse to take part in the study.

Trial locations and contacts

1 site in 1 country. Contact the study team or a site near you to ask about taking part.

Christelle JADEAU contact

+33244710781

cjadeau@ch-lemans.fr

Hikombo HITOTO, MD contact

+33243434343

hhitoto@ch-lemans.fr

France1 site, 1 recruiting
  • Centre Hospitalier Le Mans

    Le Mans, 72000

    Hikombo HITOTO, MD, 0243434343, hhitoto@ch-lemans.fr

    Recruiting

Other trials in France

About this study

Every year, between 4,000 and 6,000 people discover their seropositivity to the human immunodeficiency virus (HIV). The dynamics of new discoveries vary according to sexual orientation and birthplace. MSM born in France show the sharpest improvement, while heterosexuals born in France show a more moderate decline, and intravenous drug users (IDUs) are still at a low ebb.

There is little fine-grained data available on a national scale to explain these dynamics among people living with HIV (PLHIV).

Read more

The acquisition of Psychosocial Competencies in sexual health is a prerequisite for good sexual health. It is important for all young people, and all the more so for young people from immigrant backgrounds, whom we hypothesize, despite the limited existing literature, to be more vulnerable due to the influence of their origins, their parents' culture or language barrier, or even religion.

The primary research question: What psychosocial skills should be included in a sexual health education program for young people born in France (including those born to migrant parents), to enable them to enjoy good sexual health in adulthood?

Conditions
Sexual Health
Keywords
sexual health, psychosocial skills

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

Study groups in NCT06825247
Study groupRoleWhat they receive
Young adults born in France and living in Pays de LoireNot described

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Health education models

    Design health education models adapted to the sexual health needs of young adults born in France and living in the Pays de Loire region

    Measured: from enrollment of first patient to end of all interviews (3 years)

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted13 Feb 2025
  2. Study start1 Jun 2022
  3. Primary completionNov 2025 (estimated)
  4. Study completionNov 2025 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Cohort
Time perspective
Prospective
Enrolment
1,500 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT06825247
Sponsor's protocol ID
CHM-2022/S10/16
Acronym
ECOSSE
Status last verified
Feb 2025
First submitted
10 Feb 2025
Last updated
13 Feb 2025
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No

Questions about this trial

What is this clinical trial studying?

An observational study of Sexual Health, run by Centre Hospitalier le Mans at 1 site in France.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 3 inclusion and 2 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: looking for participants now, as of the sponsor's last update on 13 Feb 2025. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in France. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

This study is still under way. Results are not available in the source record yet.

How can a doctor refer a patient or contact the research team?

Contact Christelle JADEAU (+33244710781, cjadeau@ch-lemans.fr), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Health education models (time frame: from enrollment of first patient to end of all interviews (3 years)). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 13 Feb 2025.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in